MAZE
Maze Therapeutics, Inc.
$31.99
-0.85 (-2.59%)
At close · Jul 8
Market Cap
$1.79B
Shares
55,345,261
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$167.5M
FY2025
Net Income
-$131.12M
FY2025
Operating Margin
-85.31%
FY2025
Diluted EPS
-$3.05
FY2025
Operating Cash Flow
-$111.94M
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 |
|---|---|---|
| — | $167.5M | |
| $115.02M | $108.45M | |
| $39.04M | $34.45M | |
| $154.05M | $142.9M | |
| -$134.05M | -$142.9M | |
| — | -85.31% | |
| — | -$131.12M | |
| — | $0 | |
| -$122.54M | -$131.12M | |
| — | -78.28% | |
| — | -$131.01M | |
| USD/shares | — | -$3.05 |
| USD/shares | — | -$3.05 |
| shares | — | 42.98M |
| shares | — | 42.98M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.